Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 23% ± 5% | |
| basal cell | 3 studies | 17% ± 1% | |
| oligodendrocyte | 3 studies | 17% ± 2% | |
| hepatocyte | 3 studies | 49% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 762.45 | 459 / 459 | 100% | 12.12 | 1115 / 1118 |
| bladder | 100% | 628.43 | 21 / 21 | 100% | 8.93 | 502 / 504 |
| lung | 100% | 1098.67 | 578 / 578 | 99% | 9.18 | 1149 / 1155 |
| intestine | 100% | 796.96 | 966 / 966 | 99% | 8.84 | 524 / 527 |
| prostate | 100% | 922.76 | 245 / 245 | 99% | 5.63 | 499 / 502 |
| liver | 100% | 2611.18 | 226 / 226 | 99% | 11.96 | 402 / 406 |
| thymus | 100% | 827.00 | 653 / 653 | 99% | 7.50 | 599 / 605 |
| stomach | 100% | 579.98 | 359 / 359 | 99% | 7.40 | 283 / 286 |
| uterus | 100% | 704.44 | 170 / 170 | 99% | 7.81 | 453 / 459 |
| ovary | 100% | 934.56 | 180 / 180 | 98% | 5.67 | 423 / 430 |
| esophagus | 100% | 623.33 | 1443 / 1445 | 98% | 7.17 | 180 / 183 |
| brain | 98% | 513.88 | 2596 / 2642 | 100% | 5.94 | 704 / 705 |
| pancreas | 100% | 419.82 | 327 / 328 | 98% | 6.82 | 175 / 178 |
| adrenal gland | 100% | 1880.95 | 258 / 258 | 97% | 9.51 | 223 / 230 |
| kidney | 100% | 679.06 | 89 / 89 | 94% | 7.66 | 849 / 901 |
| skin | 100% | 690.67 | 1807 / 1809 | 93% | 7.15 | 439 / 472 |
| adipose | 100% | 584.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.20 | 29 / 29 |
| spleen | 100% | 873.02 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 7.11 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.79 | 1 / 1 |
| blood vessel | 99% | 460.26 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 677.60 | 875 / 929 | 0% | 0 | 0 / 0 |
| heart | 90% | 278.79 | 774 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 65% | 2.40 | 52 / 80 |
| muscle | 35% | 64.79 | 285 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006703 | Biological process | estrogen biosynthetic process |
| GO_0006695 | Biological process | cholesterol biosynthetic process |
| GO_0008209 | Biological process | androgen metabolic process |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0004303 | Molecular function | estradiol 17-beta-dehydrogenase [NAD(P)+] activity |
| GO_0047024 | Molecular function | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity |
| GO_0000253 | Molecular function | 3-keto sterol reductase activity |
| Gene name | HSD17B7 |
| Protein name | Hydroxysteroid 17-beta dehydrogenase 7 HCG2024989, isoform CRA_g (Hydroxysteroid 17-beta dehydrogenase 7) 3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (3-keto-steroid reductase) (EC 1.1.1.270) (Dihydrotestosterone oxidoreductase) (EC 1.1.1.210) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 37C member 1) |
| Synonyms | 17HSD7 hCG_2024989 UNQ2563/PRO6243 SDR37C1 |
| Description | FUNCTION: Bifunctional enzyme involved in steroid-hormone metabolism and cholesterol biosynthesis . Catalyzes the NADP(H)-dependent reduction of estrogens and androgens and regulates the biological potency of these steroids. Converts estrone (E1) to a more potent estrogen, 17beta-estradiol (E2) . Converts dihydrotestosterone (DHT) to its inactive form 5a-androstane-3b,17b-diol . Converts moderately progesterone to 3beta-hydroxypregn-4-ene-20-one, leading to its inactivation . Additionally, participates in the post-squalene cholesterol biosynthesis, as a 3-ketosteroid reductase . .; FUNCTION: [Isoform 3]: Does not have enzymatic activities toward E1 and DHT. . |
| Accessions | P56937 ENST00000254521.8 [P56937-1] ENST00000466176.5 V9GYN3 Q5T249 ENST00000367915.1 F2Z2C2 ENST00000470195.2 |